Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 2

Conditions

Phyllodes Tumor 2Head and Neck Neoplasms 2Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Postoperative Complications 1Liver Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1Breast Cancer Radiotherapy 1

Interventions

Cisplatin 150Radiotherapy 121Cetuximab 96Docetaxel 60Fluorouracil 56Paclitaxel 45Radiotherapy, Intensity-Modulated 41Carboplatin 40pembrolizumab 34Surveys and Questionnaires 22Erlotinib Hydrochloride 19Nivolumab 18Immunohistochemistry 16Gefitinib 16Drug Therapy 16Gemcitabine 14Pemetrexed 13Gene Expression Profiling 13durvalumab 12Chemotherapy, Adjuvant 12Radiation 11Filgrastim 11Bevacizumab 11Surgical Procedures, Operative 10Polymerase Chain Reaction 10Amifostine 10Celecoxib 9Capecitabine 9Standard of Care 8Neoadjuvant Therapy 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Head and Neck Neoplasms × Radiotherapy, Adjuvant × Clear all
NCT02395367 2025-03-07

POROMS

Beijing Stomatological Hospital, Capital Medical University

Completed
30,000 enrolled
Head & Neck

Head and Neck Neoplasms, Postoperative Complications

NCT03721757 2025-02-25

NICO

The Clatterbridge Cancer Centre NHS Foundation Trust

Phase 2 Completed
21 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡